Aethlon Medical (AEMD)

$0.77 -0.02 (-2.13%)
Market Cap 2.01M
Revenue (ttm) 0.00
Net Income (ttm) -13.39M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 859,800
Avg Vol 3,799,604
Day's Range N/A - N/A
Shares Out 2.60M
Stochastic %K 13%
Beta 1.92
Analysts Hold
Price Target $3.02

Company Profile

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.

Industry: Medical Devices
Sector: Healthcare
Phone: 619 941 0360
Fax: 619 941 0361
Address:
11555 Sorrento Valley Road, Suite 203, San Diego, United States
Meri7
Meri7 Sep. 13 at 5:38 PM
$AEMD the market cap is just over 5M now, it was 2M before close. Is the offering done?
1 · Reply
smoothest06
smoothest06 Sep. 13 at 4:57 PM
$AEMD
0 · Reply
Meri7
Meri7 Sep. 12 at 5:49 PM
$AEMD just added 33k shares now.
0 · Reply
illumantistocks
illumantistocks Sep. 12 at 4:33 PM
$AEMD right on as before as it is now folks
0 · Reply
illumantistocks
illumantistocks Sep. 12 at 4:25 PM
$AEMD well fokks are we going dollar land today i think we should start seeing a run up by 11 to 12 pst time folks
0 · Reply
illumantistocks
illumantistocks Sep. 12 at 3:36 PM
$AEMD 8 green towers on the one minute could be a repeat of the past here folks
0 · Reply
illumantistocks
illumantistocks Sep. 12 at 3:34 PM
$AEMD the other day right around 9 something she exploded i wonder if the same will happen today pst time thay is
0 · Reply
illumantistocks
illumantistocks Sep. 12 at 2:39 PM
$AEMD she needs to consolidate hopefully we have a repeat if what happened before today gents either that or we all should have gotten in $AIRE yesterday
0 · Reply
johnbig1961
johnbig1961 Sep. 12 at 1:02 PM
$AEMD
0 · Reply
johnbig1961
johnbig1961 Sep. 12 at 1:01 PM
$AEMD
0 · Reply
Latest News on AEMD
Aethlon Medical Announces Pricing of $4.5 Million Public Offering

Sep 4, 2025, 9:15 AM EDT - 10 days ago

Aethlon Medical Announces Pricing of $4.5 Million Public Offering

Aethlon Medical Announces Issuance of Hemopurifier® Patents for the Treatment of Long COVID and COVID-19-associated Coagulopathy (CAC)

Sep 3, 2025, 8:01 AM EDT - 11 days ago

Aethlon Medical Announces Issuance of Hemopurifier® Patents for the Treatment of Long COVID and COVID-19-associated Coagulopathy (CAC)

Aethlon Medical, Inc. (AEMD) Q1 2026 Earnings Call Transcript

Aug 13, 2025, 8:01 PM EDT - 4 weeks ago

Aethlon Medical, Inc. (AEMD) Q1 2026 Earnings Call Transcript

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2025, and Provides Corporate Update

Aug 13, 2025, 4:15 PM EDT - 4 weeks ago

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2025, and Provides Corporate Update

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 13, 2025

Aug 5, 2025, 8:01 AM EDT - 5 weeks ago

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 13, 2025

Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort

Jul 15, 2025, 8:01 AM EDT - 2 months ago

Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort

Aethlon Medical, Inc. (AEMD) Q4 2025 Earnings Call Transcript

Jun 26, 2025, 7:35 PM EDT - 2 months ago

Aethlon Medical, Inc. (AEMD) Q4 2025 Earnings Call Transcript

Aethlon Medical Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate Update

Jun 26, 2025, 4:15 PM EDT - 2 months ago

Aethlon Medical Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate Update

Aethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025

Jun 20, 2025, 8:01 AM EDT - 3 months ago

Aethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025

Aethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer Trial

Jun 18, 2025, 8:01 AM EDT - 3 months ago

Aethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer Trial

Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes

Jun 9, 2025, 8:01 AM EDT - 3 months ago

Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from Plasma

May 14, 2025, 8:01 AM EDT - 4 months ago

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from Plasma

Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal

Mar 10, 2025, 8:01 AM EDT - 6 months ago

Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal

Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025

Feb 13, 2025, 8:01 AM EST - 7 months ago

Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025

Aethlon Medical, Inc. (AEMD) Q3 2025 Earnings Call Transcript

Feb 12, 2025, 8:11 PM EST - 7 months ago

Aethlon Medical, Inc. (AEMD) Q3 2025 Earnings Call Transcript

Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update

Feb 12, 2025, 4:15 PM EST - 7 months ago

Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025

Feb 5, 2025, 8:01 AM EST - 7 months ago

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025

Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial

Jan 29, 2025, 8:01 AM EST - 8 months ago

Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial

Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu

Dec 20, 2024, 8:01 AM EST - 9 months ago

Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu

Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally

Nov 14, 2024, 8:00 AM EST - 10 months ago

Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally

Aethlon Medical, Inc. (AEMD) Q2 2025 Earnings Call Transcript

Nov 13, 2024, 7:58 PM EST - 10 months ago

Aethlon Medical, Inc. (AEMD) Q2 2025 Earnings Call Transcript

Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update

Nov 13, 2024, 4:15 PM EST - 10 months ago

Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update

Innovative Medical Technology Advances with First Patient Enrollments

Nov 12, 2024, 8:00 AM EST - 10 months ago

Innovative Medical Technology Advances with First Patient Enrollments

Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia

Nov 11, 2024, 8:01 AM EST - 10 months ago

Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024

Nov 6, 2024, 8:01 AM EST - 11 months ago

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024

Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit

Oct 8, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit

Immunotherapy Clinical Trials - A New Approach to Treating Cancer

Sep 19, 2024, 10:00 AM EDT - 1 year ago

Immunotherapy Clinical Trials - A New Approach to Treating Cancer

Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India

Sep 19, 2024, 8:01 AM EDT - 1 year ago

Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India

Aethlon Medical to Present at Virtual Investor Conferences in September

Sep 17, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical to Present at Virtual Investor Conferences in September

Innovation Driving Cancer's Solid Tumors Market

Sep 17, 2024, 7:30 AM EDT - 1 year ago

Innovation Driving Cancer's Solid Tumors Market

Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial

Sep 16, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial

Aethlon Medical to Present at the Life Sciences Investor Forum September 19th

Sep 13, 2024, 8:35 AM EDT - 1 year ago

Aethlon Medical to Present at the Life Sciences Investor Forum September 19th

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys

Aug 27, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys

Aethlon Medical, Inc. (AEMD) Q1 2025 Earnings Call Transcript

Aug 14, 2024, 6:45 PM EDT - 1 year ago

Aethlon Medical, Inc. (AEMD) Q1 2025 Earnings Call Transcript

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update

Aug 14, 2024, 4:15 PM EDT - 1 year ago

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update

The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors

Aug 12, 2024, 9:01 AM EDT - 1 year ago

The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors

Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial

Aug 12, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024

Aug 6, 2024, 9:12 AM EDT - 1 year ago

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024

Aethlon Medical, Inc. (AEMD) Q4 2024 Earnings Call Transcript

Jun 27, 2024, 6:37 PM EDT - 1 year ago

Aethlon Medical, Inc. (AEMD) Q4 2024 Earnings Call Transcript

Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update

Jun 27, 2024, 4:15 PM EDT - 1 year ago

Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024

Jun 21, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024

What's Next in Treatments for Cancer Patients with Solid Tumors?

Jun 20, 2024, 7:00 AM EDT - 1 year ago

What's Next in Treatments for Cancer Patients with Solid Tumors?

Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial

Jun 18, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial

The Hunt for Virus Treatments Continues Post Covid-19

Jun 7, 2024, 8:00 AM EDT - 1 year ago

The Hunt for Virus Treatments Continues Post Covid-19

Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID

Jun 3, 2024, 9:05 AM EDT - 1 year ago

Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID

Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies

Jun 3, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies

Aethlon Medical Announces Pricing of $4.7 Million Public Offering

May 15, 2024, 9:15 AM EDT - 1 year ago

Aethlon Medical Announces Pricing of $4.7 Million Public Offering

Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma

May 10, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma

Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices

Feb 21, 2024, 8:01 AM EST - 1 year ago

Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices

Aethlon Medical, Inc. (AEMD) Q3 2024 Earnings Call Transcript

Feb 14, 2024, 9:17 PM EST - 1 year ago

Aethlon Medical, Inc. (AEMD) Q3 2024 Earnings Call Transcript

Meri7
Meri7 Sep. 13 at 5:38 PM
$AEMD the market cap is just over 5M now, it was 2M before close. Is the offering done?
1 · Reply
smoothest06
smoothest06 Sep. 13 at 4:57 PM
$AEMD
0 · Reply
Meri7
Meri7 Sep. 12 at 5:49 PM
$AEMD just added 33k shares now.
0 · Reply
illumantistocks
illumantistocks Sep. 12 at 4:33 PM
$AEMD right on as before as it is now folks
0 · Reply
illumantistocks
illumantistocks Sep. 12 at 4:25 PM
$AEMD well fokks are we going dollar land today i think we should start seeing a run up by 11 to 12 pst time folks
0 · Reply
illumantistocks
illumantistocks Sep. 12 at 3:36 PM
$AEMD 8 green towers on the one minute could be a repeat of the past here folks
0 · Reply
illumantistocks
illumantistocks Sep. 12 at 3:34 PM
$AEMD the other day right around 9 something she exploded i wonder if the same will happen today pst time thay is
0 · Reply
illumantistocks
illumantistocks Sep. 12 at 2:39 PM
$AEMD she needs to consolidate hopefully we have a repeat if what happened before today gents either that or we all should have gotten in $AIRE yesterday
0 · Reply
johnbig1961
johnbig1961 Sep. 12 at 1:02 PM
$AEMD
0 · Reply
johnbig1961
johnbig1961 Sep. 12 at 1:01 PM
$AEMD
0 · Reply
smoothest06
smoothest06 Sep. 12 at 11:49 AM
$AEMD
0 · Reply
Bazzzigar
Bazzzigar Sep. 12 at 11:14 AM
$AEMD
0 · Reply
StockScanners
StockScanners Sep. 12 at 4:00 AM
$AEMD keep watch if this holds above .70
0 · Reply
STOCKSGambino
STOCKSGambino Sep. 12 at 12:18 AM
$AEMD https://x.com/StocksGambino/status/1966291969685995633
0 · Reply
HeyItsSnorlax
HeyItsSnorlax Sep. 11 at 7:45 PM
ZKIN stock will have a huge short squeeze with the 3M float locked and multiple upcoming crypto catalysts including the launch of their own cryptocurrency platform. They already have amazing financials ! Watching - $NTZ $MAMK $AEMD $SLRX $AEI
0 · Reply
Bazzzigar
Bazzzigar Sep. 11 at 7:13 PM
$AEMD after market
0 · Reply
STOCKSGambino
STOCKSGambino Sep. 11 at 6:56 PM
$AEMD https://x.com/StocksGambino/status/1966213570791698682
0 · Reply
underscoor
underscoor Sep. 11 at 6:40 PM
$AEMD $1
1 · Reply
MGeronimo
MGeronimo Sep. 11 at 6:16 PM
$AEMD ACCUMULATING AT .77 will take cheapies all day long
0 · Reply
DayTraderBatman
DayTraderBatman Sep. 11 at 5:53 PM
$AEMD Here is a crazy thought...
0 · Reply
DARKP00L
DARKP00L Sep. 11 at 5:34 PM
$AEMD this stock is a focal point today! Watch for possible shifts!
0 · Reply
S2K_TradeZ
S2K_TradeZ Sep. 11 at 5:30 PM
$AEMD 12%✅️ 0.8 break on watch next 🚨
0 · Reply